|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.230 USD | +2.35% |
|
-0.38% | +268.31% |
| 06-16 | Edesa Biotech, Inc. announced that it has received $3.5 million in funding | CI |
| 06-10 | Edesa Biotech, Inc. announced that it expects to receive $3.5 million in funding | CI |
Company Valuation: Edesa Biotech, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 46.5 | - | - |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 167.53% | - | - |
| Enterprise Value (EV) | 97.83 | 14.25 | 13.33 | 14.45 | 17.38 | 46.5 | 46.5 | 46.5 |
| Change | - | -85.44% | -6.42% | 8.4% | 20.29% | 167.53% | 0% | 0% |
| P/E | -6.71x | -0.88x | -1.51x | -2.31x | -1.94x | -3.15x | -2.6x | -2.85x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.19x | 0x | 0.1x | 0.1x | -0.1x | -0.1x | 0.33x |
| Capitalization / Revenue | - | - | - | - | - | - | - | 3x |
| EV / Revenue | - | - | - | - | - | - | - | 3x |
| EV / EBITDA | - | - | - | - | - | - | - | - |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -3.13x | -1.73x | -1.41x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.7 | -7.35 | -2.93 | -1.93 | -1.27 | -1.66 | -2.01 | -1.837 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | - | - | - | - | 15.51 |
| EBITDA | -23.56 | - | - | - | - | - | - | - |
| EBIT 1 | -23.68 | -18.37 | -9.223 | -7.015 | -7.912 | -14.84 | -26.91 | -32.94 |
| Net income 1 | -13.34 | -17.55 | -8.374 | -6.17 | -7.186 | -14.54 | -26.51 | -32.54 |
| Net Debt | - | - | - | - | - | - | - | - |
| Reference price 2 | 51.660 | 6.449 | 4.424 | 4.450 | 2.470 | 5.230 | 5.230 | 5.230 |
| Nbr of stocks (in thousands) | 1,894 | 2,209 | 3,013 | 3,247 | 7,038 | 8,892 | - | - |
| Announcement Date | 28/12/21 | 16/12/22 | 15/12/23 | 13/12/24 | 12/12/25 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.08x | - | - | - | 45.44M | |
| 21.25x | 6.51x | 14.24x | 1.5% | 56.54B | |
| 31.6x | 7.8x | 24.02x | 0.05% | 53.6B | |
| -17.91x | 4.18x | -7.32x | -.--% | 22.91B | |
| -38.06x | 12.21x | -36.05x | -.--% | 21.37B | |
| 25.45x | 4.98x | 13.18x | -.--% | 20.27B | |
| 24.28x | 4.73x | 15.36x | -.--% | 17.56B | |
| -737.38x | 35.03x | -3943.97x | -.--% | 14.75B | |
| 40.7x | 16.37x | 42.16x | 0.09% | 13.53B | |
| 16.73x | 4.82x | 11.24x | -.--% | 13.33B | |
| Average | -63.64x | 10.74x | -429.68x | 0.18% | 23.39B | |
| Weighted average by Cap. | -32.01x | 9.11x | -238.39x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EDSA Stock
- Valuation Edesa Biotech, Inc.
Select your edition
All financial news and data tailored to specific country editions
